- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Indian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
9
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
9 companies
Abbott India
Market Cap: ₹673.6b
Operates as a pharmaceutical company in India.
500488
₹31,699.95
7D
4.5%
1Y
17.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹586.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,459.70
7D
5.8%
1Y
39.9%
AstraZeneca Pharma India
Market Cap: ₹247.3b
A biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally.
506820
₹9,891.10
7D
24.9%
1Y
59.4%
Indegene
Market Cap: ₹143.0b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹595.70
7D
0.9%
1Y
12.7%
RPG Life Sciences
Market Cap: ₹35.9b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,169.20
7D
0.5%
1Y
49.6%
Novartis India
Market Cap: ₹24.7b
Operates as a healthcare company in India.
500672
₹1,001.80
7D
-5.8%
1Y
-1.6%
Jagsonpal Pharmaceuticals
Market Cap: ₹15.5b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹233.81
7D
-3.6%
1Y
78.0%
Alpa Laboratories
Market Cap: ₹2.1b
Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.
ALPA
₹97.65
7D
-6.6%
1Y
20.0%
Par Drugs and Chemicals
Market Cap: ₹1.2b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹100.51
7D
-1.5%
1Y
-55.9%